Ocugen (OCGN) Enterprise Value Growth (1y) (2015 - 2025)
Ocugen (OCGN) Enterprise Value Growth (1y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
-43.18% |
| Jun 30, 2024 |
77.76% |
| Mar 31, 2024 |
65.59% |
| Dec 31, 2023 |
56.60% |
| Sep 30, 2023 |
47.37% |
| Jun 30, 2023 |
38.63% |
| Mar 31, 2023 |
40.88% |
| Dec 31, 2022 |
4.24% |
| Sep 30, 2022 |
5.35% |
| Jun 30, 2022 |
0.55% |
| Mar 31, 2022 |
-189.72% |
| Dec 31, 2021 |
-295.02% |
| Sep 30, 2021 |
-461.86% |
| Jun 30, 2021 |
-672.59% |
| Mar 31, 2021 |
-1,302.82% |
| Dec 31, 2020 |
-222.93% |
| Sep 30, 2020 |
-24.87% |
| Jun 30, 2020 |
-2,106.07% |
| Mar 31, 2020 |
-934.28% |
| Dec 31, 2019 |
-357.21% |
